Revolutions Medical Corporation Files Pre Market 510K Application With The FDA For 3cc Rev Vac Safety Syringe Revolutions Medical Corporation (OTCBB: RMCP) today filed its 510k application with the Food and Drug Administration for its proprietary 3cc Rev Vac Safety Syringe. The Rev Vac safety syringe uses patented technology to draw the needle into the syringe chamber after use. This safety syringe should result in a major decrease in accidental needle stick injuries.
Source: www.medicalnewstoday.comHumana Reports 40% Decrease In Q3 Earnings In Part Because Of Lower Medicare Drug Plan Revenues Humana on Monday announced that third-quarter earnings decreased by 40% to $183 million, or $1.09 per share, from $302.4 million, or $1.78 per share, a year earlier, in large part because of investment losses and an expected decrease in premium revenue from Medicare
prescription drug plans, the AP/Seattle Times reports.
Source: www.medicalnewstoday.com"The Global Burden Of Disease - 2004 Update" World Health Organization A response to the need for comprehensive, consistent and comparable information on diseases and injuries at global and regional level. The global burden of disease: 2004 update is a comprehensive assessment of the
health of the world's population.
Source: www.medicalnewstoday.comNews From The Journal Of The National Cancer Institute, Oct. 28 Skewed X Inactivation in BRCA1 Mutation Carriers One X chromosome is more frequently silenced than the other X chromosome in women who carry mutations in the BRCA1 gene, and the skewed X inactivation is associated with a later onset of breast or ovarian cancer in these women. Each cell in a woman's body carries two X chromosomes, while those of a man carry only one X chromosome.
Source: www.medicalnewstoday.comCHEST 2008: New Pulmonary Hypertension Research Presented #6363 TADALAFIL PROVES EFFECTIVE THERAPY FOR PULMONARY HYPERTENSION New research shows that the erectile dysfunction drug, tadalafil, may be an effective adjunct therapy for patients with pulmonary arterial hypertension (PAH). Italian researchers randomized 405 patients with PAH, of whom 53 percent were taking concomitant bosentan, to two study arms. The groups received either tadalafil or placebo orally once daily as monotherapy or as add-on therapy to bosentan.
Source: www.medicalnewstoday.comWorld First Early Stage Diagnostic Test For Ovarian Cancer There is new hope for women around the world, with the launch of an early detection test for ovarian cancer. The test, developed in Melbourne by
HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample. Two Victorian women have become the first test recipients.
Source: www.medicalnewstoday.comWomen With Breast Implants Encouraged To Go Beyond Regular Mammogram Screening NewImage.com, the premier online destination for personal image enhancement solutions, is pleased to support National Breast Cancer Awareness Month for a second year by helping raise awareness of the importance of early detection and encouraging women with breast implants to go beyond regular mammography screenings to reduce the risk of possibly missing a tumor hidden under an implant.
Source: www.medicalnewstoday.comBlogs Comment On Privacy Rights, Faith-based Pharmacies, Parental Involvement Laws The following is a summary of selected women's
health-related blogs.~ "A Stealth Attack on Privacy," Amanda Marcotte, RH Reality Check:"Anti-choicers who petulantly claim that there's no right to privacy in the Constitution are attacking many more decisions than Roe," Marcotte writes. She writes that "Roe was just the logical conclusion of a decision made by the Court eight years earlier.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
